The adaptive metabolic plasticity mightallow CSCs, for example, CD110+ colorectal cancer tumor-initiating cells (TICs), brain tumor-initiating cells, and resistant CSC clones, to survive in changeable, especially in hostile metastatic environments or unfavorable circumstances38. The gene discussed is MPL; the disease is brain neoplasm.